A cost-utility analysis of low-dose hormone replacement therapy in postmenopausal women with an intact uterus.

<h4>Objective</h4>The objective of this study was to evaluate the cost utility of one year's treatment with a low-dose conjugated estrogen/medroxyprogesterone acetate (CE/MPA low dose) preparation (Premique Low Dose [Wyeth Pharmaceuticals, Maidenhead, UK]), compared with a higher-dose preparation (P... View More